Page 80 - Read Online
P. 80

Maisel et al. J Cancer Metastasis Treat 2019;5:7  I  http://dx.doi.org/10.20517/2394-4722.2018.82                          Page 11 of 14

               20.  De Camilli P, Emr SD, McPherson PS, Novick P. Phosphoinositides as regulators in membrane traffic. Science 1996;271:1533-9.
               21.  Kurten RC, Cadena DL, Gill GN. Enhanced degradation of EGF receptors by a sorting nexin, SNX1. Science 1996;272:1008-10.
               22.  Duclos CM, Champagne A, Carrier JC, Saucier C, Lavoie CL, et al. Caspases play in traffic. Cell Death Dis 2017;8:e2636.
               23.  Chin LS, Raynor MC, Wei X, Chen HQ, Li L, et al. Hrs interacts with sorting nexin 1 and regulates degradation of epidermal growth factor
                   receptor. J Biol Chem 2001;276:7069-78.
               24.  Yang XZ, Li XX, Zhang YJ, Rodriguez-Rodriguez L, Xiang MQ, et al. Rab1 in cell signaling, cancer and other diseases. Oncogene
                   2016;35:5699-704.
               25.  Chia WJ, Tang BL. Emerging roles for Rab family GTPases in human cancer. Biochim Biophys Acta 2009;1795:110-6.
               26.  Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol 2009;10:513-25.
               27.  Cheng KW, Lahad JP, Gray JW, Mills GB. Emerging role of RAB GTPases in cancer and human disease. Cancer Res 2005;65:2516-9.
               28.  Short B, Preisinger C, Schaletzky J, Kopajtich R, Barr FA. The Rab6 GTPase regulates recruitment of the dynactin complex to Golgi
                   membrane. Curr Biol 2002;12:1792-5.
               29.  Ceresa BP. Regulation of EGFR endocytic trafficking by rab proteins. Histol Histopathol 2006;21:987-93.
               30.  Zhou Y, Wu B, Li JH, Nan G, Jiang JL, et al. Rab22a enhances CD147 recycling and is required for lung cancer cell migration and invasion.
                   Exp Cell Res 2017;357:9-16.
               31.  Xiong F, Liu K, Zhang F, Sha K1 Wang X. et al. MiR-204 inhibits the proliferation and invasion of renal cell carcinoma by inhibiting
                   RAB22A expression. Oncol Rep 2016;35:3000-8.
               32.  Wang T, Gilkes DM, Takano N, Xiang L, Luo W, et al. Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that
                   stimulate breast cancer invasion and metastasis. Proc Natl Acad Sci U S A 2014;111:E3234-42.
               33.  Zhang Y, Zhao FJ, Chen LL, Wang LQ, Nephew KP, et al. MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and
                   metastasis in ovarian cancer. Oncotarget 2014;5:12291-303.
               34.  Yang D, Liu G, Wang K. miR-203 acts as a tumor suppressor gene in osteosarcoma by regulating RAB22A. PLoS One 2015;10:e0132225.
               35.  Mallard F, Tang BL, Galli T, Tenza D, Saint-Pol A, et al. Early/recycling endosomes-to-TGN transport involves two SNARE complexes and
                   a Rab6 isoform. J Cell Biol 2002;156:653-64.
               36.  Galvez T, Gilleron J, Zerial M, O’Sullivan GA. SnapShot: mammalian rab proteins in endocytic trafficking. Cell 2012;151:234-e2.
               37.  White J, Johannes L, Mallard F, Girod A, Grill S, et al. Rab6 coordinates a novel Golgi to ER retrograde transport pathway in live cells. J
                   Cell Biol 1999;147:743-60.
               38.  Personnic N, Bärlocher K, Finsel I, Hilbi H. Subversion of retrograde trafficking by translocated pathogen effectors. Trends Microbiol
                   2016;24:450-62.
               39.  Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, et al. Breast cancer classification and prognosis based on gene expression profiles
                   from a population-based study. Proc Natl Acad Sci U S A 2003;100:10393-8.
               40.  Scott KL, Kabbarah O, Liang MC, Ivanova E, Anagnostou V, et al. GOLPH3 modulates mTOR signalling and rapamycin sensitivity in
                   cancer. Nature 2009;459:1085-90.
               41.  Maisel S, Broka D, Schroeder J. Intravesicular epidermal growth factor receptor subject to retrograde trafficking drives epidermal growth
                   factor-dependent migration. Oncotarget 2017;9:6463-77.
               42.  Greenwood E, Maisel S, Ebertz D, Russ A, Pandey R, et al. Llgl1 prevents metaplastic survival driven by epidermal growth factor
                   dependent migration. Oncotarget 2016;7:60776-92.
               43.  Merlin J, Stechly L, de Beaucé S, Monté D, Leteurtre E, et al. Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR
                   downstream pathways in pancreatic cancer cells. Oncogene 2011;30:2514-25.
               44.  Khan EM, Heidinger JM, Levy M, Lisanti MP, Ravid T, et al. Epidermal growth factor receptor exposed to oxidative stress undergoes Src-
                   and caveolin-1-dependent perinuclear trafficking. J Biol Chem 2006;281:14486-93.
               45.  Chung BM, Raja SM, Clubb RJ, Tu C, George M, et al. Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic
                   recycling pathway promotes interaction with Src. BMC Cell Biol 2009;10:84.
               46.  Maher PA. Nuclear translocation of fibroblast growth factor (FGF) receptors in response to FGF-2. J Cell Biol 1996;134:529-36.
               47.  Mitchell H, Choudhury A, Pagano RE, Leof EB. Ligand-dependent and -independent transforming growth factor-beta receptor recycling
                   regulated by clathrin-mediated endocytosis and Rab11. Mol Biol Cell 2004;15:4166-78.
               48.  Shewan AM, van Dam EM, Martin S, Luen TB, Hong W, et al. GLUT4 recycles via a trans-Golgi network (TGN) subdomain enriched in
                   syntaxins 6 and 16 but not TGN38: involvement of an acidic targeting motif. Mol Biol Cell 2003;14:973-86.
               49.  Ralston E, Ploug T. GLUT4 in cultured skeletal myotubes is segregated from the transferrin receptor and stored in vesicles associated with
                   TGN. J Cell Sci 1996;109:2967-78.
               50.  Kanzaki M. Insulin receptor signals regulating GLUT4 translocation and actin dynamics. Endocr J 2006;53:267-93.
               51.  Zhang H, Fagan DH, Zeng X, Freeman KT, Sachdev D, et al. Inhibition of cancer cell proliferation and metastasis by insulin receptor
                   downregulation. Oncogene 2010;29:2517-27.
               52.  Dearth RK, Cui X, Kim HJ, Kuiatse I, Lawrence NA, et al. Mammary tumorigenesis and metastasis caused by overexpression of insulin
                   receptor substrate 1 (IRS-1) or IRS-2. Mol Cell Biol 2006;26:9302-14.
               53.  Bryant DM, Wylie FG, Stow JL. Regulation of endocytosis, nuclear translocation, and signaling of fibroblast growth factor receptor 1 by
                   E-cadherin. Mol Biol Cell 2005;16:14-23.
               54.  Carpenter G. Nuclear localization and possible functions of receptor tyrosine kinases. Curr Opin Cell Biol 2003;15:143-8.
               55.  Reilly JF, Maher PA. Importin beta-mediated nuclear import of fibroblast growth factor receptor: role in cell proliferation. J Cell Biol
                   2001;152:1307-12.
               56.  Bitler BG, Goverdhan A, Schroeder JA. MUC1 regulates nuclear localization and function of the epidermal growth factor receptor. J Cell
                   Sci 2010;123:1716-23.
               57.  Ye T, Wei X, Yin T, Xia Y, Li D, et al. Inhibition of FGFR signaling by PD173074 improves antitumor immunity and impairs breast cancer
   75   76   77   78   79   80   81   82   83   84   85